Universal Biosensors, Inc. Stock price

Equities

UBI

AU000000UBI2

Advanced Medical Equipment & Technology

Market Closed - Australian S.E. 01:10:10 2024-03-28 am EDT 5-day change 1st Jan Change
0.2 AUD +5.26% Intraday chart for Universal Biosensors, Inc. -6.98% 0.00%
Sales 2022 4.52M 2.95M Sales 2023 6.63M 4.32M Capitalization 42.47M 27.67M
Net income 2022 -26M -16.94M Net income 2023 -6M -3.91M EV / Sales 2022 5.86 x
Net cash position 2022 21.15M 13.78M Net cash position 2023 5.27M 3.43M EV / Sales 2023 5.61 x
P/E ratio 2022
-1.67 x
P/E ratio 2023
-6.3 x
Employees 80
Yield 2022 *
-
Yield 2023
-
Free-Float 67.12%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Universal Biosensors, Inc.

1 day+5.26%
1 week-6.98%
Current month+25.00%
1 month+37.93%
3 months-4.76%
6 months-28.57%
More quotes
1 week
0.18
Extreme 0.18
0.22
1 month
0.14
Extreme 0.135
0.30
Current year
0.14
Extreme 0.135
0.30
1 year
0.14
Extreme 0.135
0.32
3 years
0.14
Extreme 0.135
1.04
5 years
0.13
Extreme 0.13
1.04
10 years
0.13
Extreme 0.13
1.04
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 20-03-05
Director of Finance/CFO 55 06-10-31
Chief Operating Officer - -
Members of the board TitleAgeSince
Director/Board Member 58 16-06-29
Director/Board Member 68 15-03-11
Director/Board Member 64 16-03-01
More insiders
Date Price Change Volume
24-03-28 0.2 +5.26% 872 369
24-03-27 0.19 0.00% 311,752
24-03-26 0.19 -5.00% 664,411
24-03-25 0.2 -4.76% 677,217
24-03-22 0.21 -4.55% 810,170

Delayed Quote Australian S.E., March 28, 2024 at 01:10 am EDT

More quotes
Universal Biosensors, Inc. is a biosensor company. The Company is engaged in developing and commercializing a range of biosensors in oenology (wine industry), human health including oncology, coagulation, women’s health and fertility, non-human and environmental testing using its platform technology and hand-held point-of-use devices. Its core technology consists of a disposable, multi-layer test strip, which incorporates an electrochemical sensing system using opposing electrodes that detect specific analytes in samples as small as a droplet. Its products include Sentia Wine Analyzer, Xprecia Prime Coagulation Analyzer, Hemostasis Reference Laboratory (HRL) and PETRACKR Veterinary Blood Glucose Monitoring System. HRL supports contract research organizations, central laboratories, early phase clinics, pharmaceutical/ biotechnology companies and academic researchers conducting clinical trials. HRL offers multiplex cytokine analysis on the MESO QuickPlex SQ 120MM technology platform.
More about the company

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Universal Biosensors, Inc. - Australian S.E.